glutathione mutations in sclc patients

glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer Oncology Reports

Name: glutathione mutations in sclc patients Increased antioxidative defense and reduced advanced glycation end-product formation by metabolic adaptation non-small-cell-lung-cancer Oncology Reports
Brand: lcog.de
SKU: 34464044486
Price: 28.78 USD
Availability: InStock
Rating: 4.4419 (22 reviews)

Oncology Reports In vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Science Advances The flavonoid GL V9 induces oxidative stress mediated apoptosis in small cell lung cancer by promoting STEAP3 degradation ScienceDirect Immunotherapy in small cell lung cancer: from molecular promises to clinical challenges Journal for ImmunoTherapy of Cancer Cell Death, Molecular Targeted Therapies, and Metabolic Reprogramming in EGFR Mutant Lung Cancer

SKU: 34464044486 · From lcog.de

4.4

USD28.78 USD77.78

Pay in 4 interest-free payments of $7.20 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

L.RennieN.MurphyV

Importantly, we established that ultrafiltered flavan-3,3,4-triol (4 ) was converted to cyanidin ( 8 ) by additional well-characterized arGSTs from maize ( Zm BZ2), arabidopsis ( A tTT19) and grapevine ( Vv GST4), and from the structure-elucidated phi-class orthologue from poplar ( Pt GSTF8), while application of GSTs unrelated to anthocyanin biosynthesis ( Vv GST2, Vv GST5, At GSTF2) did not result in cyanidin ( 8 ) formation (Fig